{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:36:10Z","timestamp":1785796570540,"version":"3.56.0"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intravitreal bevacizumab has been used off\u2010label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020. There is limited safety data for the off\u2010label intravitreal use of MVASI. This retrospective study evaluates the safety of intravitreal MVASI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective review of all eyes that were given intravitreal MVASI at all metropolitan public hospitals in South Australia between 1st May 2022 and 30th May 2024. Demographic data, injection indications, number of injections per eye, whether patients were switched to another agent, and associated complications were collected from electronic and paper medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 6230 injections were given to 1682 eyes in this study. The mean age of the study population was 69.8\u2009\u00b1\u200915.6\u2009years. The overall mean number of MVASI injections given per eye was 3.7\u2009\u00b1\u20092.9 (range 1\u201321). The indications for treatment were neovascular age\u2010related macular degeneration (2106 injections; 33.8%), diabetic macular oedema (1634 injections; 26.2%), branch retinal vein occlusion (695 injections; 11.2%), proliferative diabetic retinopathy (596 injections; 9.6%), central retinal vein occlusion (558 injections; 9.0%) and other (641 injections; 10.3%). Significant sight\u2010threatening complications included 3 cases of bacterial endophthalmitis (0.05%) and 3 cases of uveitis (0.05%). No cases of retinal vasculitis were observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intravitreal MVASI had a similar ophthalmic safety profile and may be used as an alternative to Avastin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ceo.14515","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:30:06Z","timestamp":1741714206000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety of an Intravitreal Bevacizumab Biosimilar (\n                    <scp>MVASI<\/scp>\n                    )"],"prefix":"10.1111","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2270-9060","authenticated-orcid":false,"given":"Hanru","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology The Queen Elizabeth Hospital  Woodville South South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobak","family":"Bahrami","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology The Queen Elizabeth Hospital  Woodville South South Australia Australia"},{"name":"The Discipline of Ophthalmology and Visual Sciences The University of Adelaide  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-710X","authenticated-orcid":false,"given":"Sonia","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology The Queen Elizabeth Hospital  Woodville South South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Tahmasebi Sarvestani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Modbury Hospital  Modbury SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Cugati","sequence":"additional","affiliation":[{"name":"The Discipline of Ophthalmology and Visual Sciences The University of Adelaide  Adelaide South Australia Australia"},{"name":"Department of Ophthalmology Modbury Hospital  Modbury SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Lake","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Flinders Medical Centre  Bedford Park South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weng Onn","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology The Queen Elizabeth Hospital  Woodville South South Australia Australia"},{"name":"The Discipline of Ophthalmology and Visual Sciences The University of Adelaide  Adelaide South Australia Australia"},{"name":"Department of Ophthalmology Royal Adelaide Hospital  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj","family":"Supramaniam","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Modbury Hospital  Modbury SA Australia"},{"name":"Department of Ophthalmology Flinders Medical Centre  Bedford Park South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology The Queen Elizabeth Hospital  Woodville South South Australia Australia"},{"name":"The Discipline of Ophthalmology and Visual Sciences The University of Adelaide  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1987"},{"key":"e_1_2_8_3_1","unstructured":"P. J.Rosenfeld \u201cThe Path to Intravitreal Bevacizumab A Logical Decision Based on Scientific Facts and Clinical Intuition \u201d(2009) Retina Today 26\u201029."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20050701-14"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20050701-15"},{"key":"e_1_2_8_6_1","first-page":"1383","article-title":"Intravitreal Injection of Bevacizumab in Diabetic Macular Edema","volume":"30","author":"Ateeq A.","year":"2014","journal-title":"Pakistan Journal of Medical Sciences"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.09.038"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.03.021"},{"key":"e_1_2_8_10_1","unstructured":"\u201cBevacizumab Biosimilar Now PBS\u2010Listed \u201d(2024) https:\/\/www.nps.org.au\/radar\/articles\/bevacizumab\u2010biosimilar\u2010now\u2010pbs\u2010listed."},{"key":"e_1_2_8_11_1","unstructured":"Therapeutic Goods Administration Bevacizumab\u2013Medicine Shortage Information(2021) Canberra: TGA https:\/\/apps.tga.gov.au\/Prod\/msi\/Search\/."},{"key":"e_1_2_8_12_1","unstructured":"Pharmaceutical Benefits Advisory Committee \u201cPublic Summary Document\u2014November 2020 PBAC Meeting Bevacizumab \u201d(2020) Canberra: Australian Government Department of Health https:\/\/www.pbs.gov.au\/industry\/listing\/elements\/pbac\u2010meetings\/psd\/2020\u201011\/files\/bevacizumab\u2010psd\u2010nov\u20102020.pdf."},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.7.17"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-020-00133-1"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v16i1.8248"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.21474\/IJAR01\/6234"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0636-3"},{"key":"e_1_2_8_18_1","unstructured":"\u201cPolicy Statement: The Use of Biosimilars in Opthalmic Practice\u20142022 \u201dhttps:\/\/www.aao.org\/education\/clinical\u2010statement\/use\u2010of\u2010biosimilars\u2010in\u2010ophthalmic\u2010practice."},{"key":"e_1_2_8_19_1","unstructured":"\u201cASRS Recommendations Regarding the Use of Biosimilar Anti\u2010VEGF Products \u201dhttps:\/\/www.asrs.org\/content\/documents\/asrs\u2010biosimilars\u2010statement.docx.pdf."},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182278ab4"},{"key":"e_1_2_8_21_1","unstructured":"U.S. Food and Drug Administration \u201cBiosimilar Product Information \u201dhttps:\/\/www.fda.gov\/drugs\/biosimilars\/biosimilar\u2010product\u2010information."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.3458"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.2260"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004174"},{"key":"e_1_2_8_25_1","unstructured":"\u201cPavblu Product Information \u201dhttps:\/\/www.pavblu.com\/safety\u2010efficacy."},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.5403"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.031"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2024.06.013"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2024.02.012"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_992_16"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.05.062"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-007-0660-z"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417\u2010018\u201004213\u2010x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.02.028"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02553-5"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(22)00010\u20101"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6654168"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01909-z"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ceo.14515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ceo.14515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:10:38Z","timestamp":1773648638000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ceo.14515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/ceo.14515"],"URL":"https:\/\/doi.org\/10.1111\/ceo.14515","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"2024-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}